Prophylactic beta-blocker therapy: clinical implications of an aggregate analysis

Hepatology. 1992 Feb;15(2):354-6. doi: 10.1002/hep.1840150229.

Authors

T F Imperiale¹, A J McCullough

Affiliation

¹ Division of Internal Medicine, Case Western Reserve University, Cleveland, Ohio 44109.

PMID: 1346523
DOI: 10.1002/hep.1840150229

No abstract available

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Esophageal and Gastric Varices / complications
Gastrointestinal Hemorrhage / prevention & control*
Humans
Liver Cirrhosis / complications
Randomized Controlled Trials as Topic

Substances

Adrenergic beta-Antagonists